Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VALIC Company I Large Capital Growth Fund (VLCGX)

11.62
Net Asset Value
-2.76%
1 Day
-22.58%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
0.76%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term growth of capital. The fund seeks to meet its objective by investing, normally, at least 80% of its net assets in securities of large-cap companies. In complying with this 80% investment requirement, the fund will invest primarily in common stocks. Generally, large-cap companies will include companies whose market capitalizations, at the time of purchase, are equal to or greater than the market capitalization of the smallest company in the Russell 1000  Index during the most recent 12-month period.

Performance

1 month-6.86% 3 years+12.34%
3 months-6.27% 5 years+13.22%
1 year+2.21% Since inception+6.54%
Data through --

Peer Comparisonvs. Large growth

 VLCGXCategory
Performance 5-yr return+13.22%+16.96%
Expense ratio0.76%1.20%
Risk 5 year sharpe ratio1.021.19
Net assets$417.6M$2.8B
Average market cap$51.5B$81.2B
Average P/E21.623.1
Portfolio turnover26%26%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVALIC
Fund manager & tenureJeffrey Constantino / 1 Years
Minimal initial investment$0.00
Minimum IRA investment--

Holdings

U.S. stock90.27%
International stock8.89%
Fixed income0.84%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Hardware 14.42%
Industrial materials 13.91%
Consumer service 12.22%
Healthcare 11.00%
Energy 10.72%
Top 10 Holdings
Portfolio weighting
ACN Accenture4.42%
GOOGL Google4.24%
V Visa4.00%
CL Colgate-Palmolive3.32%
DHR Danaher Corp3.30%
CVS CVS Caremark2.65%
ORCL Oracle2.65%
AAPL Apple2.55%
UTX United Technologies2.54%
TMO Thermo Fisher Scientific Inc2.47%

Partner Offers